The circulating level of FABP3 is an indirect biomarker of microRNA-1

Journal of the American College of Cardiology

Volumn 61, Issue 1, 2013, Pages 88-95

  Varrone, Francesca ^a   Gargano, Barbara ^a   Carullo, Pierluigi ^b,c   Di Silvestre, Dario ^d   De Palma, Antonella ^d   Grasso, Ludovica ^e   Di Somma, Carolina ^f   Mauri, Pierluigi ^d   Benazzi, Louise ^d   Franzone, Anna ^e   Jotti, Gloria Saccani ^g   Bang, Marie Louise ^b,c   Esposito, Giovanni ^e   Colao, Annamaria ^e   Condorelli, Gianluigi ^b,c   Catalucci, Daniele ^b,c  

^a IRCCS MULTIMEDICA   (Italy)

^b Milan Unit   (Italy)

^c HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^d INSTITUTE OF BIOMEDICAL TECHNOLOGIES   (Italy)

^e UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^f IRCCS SDN   (Italy)

^g UNIVERSITY OF PARMA   (Italy)

Author keywords

biomarker; cardiovascular diseases; FABP3; microRNA; miR 1

Indexed keywords

BIOLOGICAL MARKER; FATTY ACID BINDING PROTEIN; MICRORNA 1; PROTEIN FABP3; UNCLASSIFIED DRUG;

ACROMEGALY; ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA VALVE STENOSIS; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GROWTH HORMONE DEFICIENCY; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE OVERLOAD; HEART MUSCLE CELL; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN TARGETING; PROTEOMICS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUPERNATANT; TISSUE LEVEL; TRANSGENIC MOUSE; WILD TYPE;

ACROMEGALY; ANIMALS; AORTIC VALVE STENOSIS; BIOLOGICAL MARKERS; CELLS, CULTURED; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FASTING; FATTY ACID-BINDING PROTEINS; HUMAN GROWTH HORMONE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; INSULIN-LIKE GROWTH FACTOR I; MICE; MICRORNAS; MYOCARDIUM; MYOCYTES, CARDIAC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 84872038762     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2012.08.1003     Document Type: Article

References (27)

1. M.A. Sussman, A. McCulloch, T.K. Borg Dance band on the Titanic: biomechanical signaling in cardiac hypertrophy Circ Res 91 2002 888 898
2. G.W. Dorn 2nd MicroRNAs in cardiac disease Transl Res 157 2011 226 235
3. L. Elia, R. Contu, M. Quintavalle Reciprocal regulation of microRNA-1 and insulin-like growth factor-1 signal transduction cascade in cardiac and skeletal muscle in physiological and pathological conditions Circulation 120 2009 2377 2385
4. R. Kumarswamy, A.R. Lyon, I. Volkmann SERCA2a gene therapy restores microRNA-1 expression in heart failure via an Akt/FoxO3A-dependent pathway Eur Heart J 33 2012 1067 1075
5. M. Furuhashi, G.S. Hotamisligil Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets Nat Rev Drug Discov 7 2008 489 503
6. C. Comunian, F. Rusconi, A. De Palma, P. Brunetti, D. Catalucci, P.L. Mauri A comparative MudPIT analysis identifies different expression profiles in heart compartments Proteomics Clin Appl 5 2011 564
7. P. Gururajan, P. Gurumurthy, P. Nayar, G. Srinivasa Nageswara Rao, S. Babu, K.M. Cherian Heart fatty acid binding protein (H-FABP) as a diagnostic biomarker in patients with acute coronary syndrome Heart Lung Circ 19 2010 660 664
8. D. Didiano, O. Hobert Perfect seed pairing is not a generally reliable predictor for miRNA-target interactions Nat Struct Mol Biol 13 2006 849 851
9. J. Suarez, B. Gloss, D.D. Belke Doxycycline inducible expression of SERCA2a improves calcium handling and reverts cardiac dysfunction in pressure overload-induced cardiac hypertrophy Am J Physiol Heart Circ Physiol 287 2004 H2164 H2172
10. A. Care, D. Catalucci, F. Felicetti MicroRNA-133 controls cardiac hypertrophy Nat Med 13 2007 613 618
11. D. Sayed, C. Hong, I.Y. Chen, J. Lypowy, M. Abdellatif MicroRNAs play an essential role in the development of cardiac hypertrophy Circ Res 100 2007 416 424
12. L. Fontana, E.P. Weiss, D.T. Villareal, S. Klein, J.O. Holloszy Long-term effects of calorie or protein restriction on serum IGF-1 and IGFBP-3 concentration in humans Aging Cell 7 2008 681 687
13. A. Cittadini, A. Cuocolo, B. Merola Impaired cardiac performance in GH-deficient adults and its improvement after GH replacement Am J Physiol 267 1994 E219 E225
14. P. Sonksen Reflections from a 40 year journey with growth hormone and IGF-I Growth Horm IGF Res 11 2001 329 335
15. C.A. Benbassat, K.C. Maki, T.G. Unterman Circulating levels of insulin-like growth factor (IGF) binding protein-1 and -3 in aging men: relationships to insulin, glucose, IGF, and dehydroepiandrosterone sulfate levels and anthropometric measures J Clin Endocrinol Metab 82 1997 1484 1491
16. G. Lombardi, M. Galdiero, R.S. Auriemma, R. Pivonello, A. Colao Acromegaly and the cardiovascular system Neuroendocrinology 83 2006 211 217
17. L. Sacca, A. Cittadini, S. Fazio Growth hormone and the heart Endocr Rev 15 1994 555 573
18. H. Bihan, C. Espinosa, H. Valdes-Socin Long-term outcome of patients with acromegaly and congestive heart failure J Clin Endocrinol Metab 89 2004 5308 5313
19. A. Colao The GH-IGF-I axis and the cardiovascular system: clinical implications Clin Endocrinol (Oxf) 69 2008 347 358
20. M. Han, J. Toli, M. Abdellatif MicroRNAs in the cardiovascular system Curr Opin Cardiol 26 2011 181 189
21. J. Ai, R. Zhang, X. Gao Overexpression of microRNA-1 impairs cardiac contractile function by damaging sarcomere assembly Cardiovasc Res 95 2012 385 393
22. B. Yang, H. Lin, J. Xiao The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2 Nat Med 13 2007 486 491
23. I.N. King, L. Qian, J. Liang A genome-wide screen reveals a role for microRNA-1 in modulating cardiac cell polarity Dev Cell 20 2011 497 510
24. J. Sadoshima, S. Izumo The cellular and molecular response of cardiac myocytes to mechanical stress Annu Rev Physiol 59 1997 551 571
25. U. O'Sullivan, P.D. Gluckman, B.H. Breier, S. Woodall, R.A. Siddiqui, S.N. McCutcheon Insulin-like growth factor-1 (IGF-1) in mice reduces weight loss during starvation Endocrinology 125 1989 2793 2794
26. K. Setsuta, Y. Seino, T. Ogawa, M. Arao, Y. Miyatake, T. Takano Use of cytosolic and myofibril markers in the detection of ongoing myocardial damage in patients with chronic heart failure Am J Med 113 2002 717 722
27. T. Niizeki, Y. Takeishi, T. Arimoto Serum heart-type fatty acid binding protein predicts cardiac events in elderly patients with chronic heart failure J Cardiol 46 2005 9 15